Dr Elena Nikiphorou is a renowned consultant rheumatologist who sees patients at The London Clinic on Harley Street. She has a clinical interest in rheumatoid arthritis and spondyloarthritis, with relevant research qualifications (MD(Res) and PhD). She has expertise in all aspects of general rheumatology, including connective tissue and metabolic bone disease; crystal and reactive arthritis.

Dr Nikiphorou has a clinical and academic interest in inflammatory arthritis (IA). She completed her MBBS at University College London and obtained a first-class honours for her Intercalated BSc in Physiology. She was also awarded a British Pharmacological Society Award and a Wellcome Trust Vacation Scholarship for her BSc research. Following a number of diverse medical rotations in London as a junior doctor, she completed her rheumatology training at Addenbrooke’s Hospital, Cambridge. During this time, she was awarded a CLRN Research Associate Fellowship which culminated in her MD research at University College London, examining structural outcomes in rheumatoid arthritis (RA). Her interest in inflammatory arthritis has prompted further international research, this time with a focus in spondyloarthritis, resulting in a second research degree, namely a PhD from Leiden University in The Netherlands.

Dr Nikiphorou is currently a consultant rheumatologist at King’s College Hospital and an Adjunct Senior Lecturer at King’s College London. She has been the recipient of multiple awards, bursaries and competitive roles. One of these awards was the Richard Kovacs prize by the Royal Society of Medicine in 2014, which supported a fellowship in Chicago. She also received the Doris Hillier grant from the British Medical Association in 2018, to support her work on multimorbidity in rheumatoid arthritis and the development of management algorithms according to individual needs.

At international level, she has been the recipient of several international bursaries and awards, including a European League Against Rheumatism (EULAR)-funded educational training fellowship in Finland and an Assessment of SpondyloArthritis International Society (ASAS) award in collaboration with Leiden University, The Netherlands. She currently holds an early career grant with FOREUM undertaking research in refractory rheumatoid arthritis. 

Dr Nikiphorou is involved in a number of national and international rheumatology societies and initiatives. She is a trained EULAR Methodologist and has had key roles in working groups for the development of international management and other recommendations. She has held a number of leadership positions over the years, including the Presidentship of the Rheumatology & Rehabilitation section at The Royal Society of Medicine and the Chair of the largest network of young rheumatologists and researchers in Europe (The Emerging EULAR Network).

116 Harley Street
London W1G 7JL

• Consultant Rheumatologist
  King's College Hospital
• Adjunct Senior Lecturer
  King's College London

• Lecturer
  PassPaces

• Year qualified 2004
• University College London 1998 - 2004

New thinking needed on methotrexate and ILD

The limbic

15/11/2019

A team of UK rheumatologists has urged clinicians to not delay treatment with methotrexate in rheumatoid arthritis because of fears over lung injury.

Obesity Linked to Lower Remission, Higher Disability in Rheumatoid Arthritis Patients

American College of Rheumatology

04/11/2017

Patients with rheumatoid arthritis whose body-mass index scores are higher have lower rates of remission and higher rates of disability, and effective weight screening and management should be a central feature of RA management.

Predictors of RA-Related Joint Surgery Analyzed

Clinical Pain Advisor

19/06/2015

Patients with moderate disease activity who are taking conventional disease-modifying antirheumatic drugs (DMARD) have a similar risk of joint surgery as those with high disease activity

Patients with moderate RA as likely to need joint surgery as those with high disease

EurekAlert!

10/06/2015

Patients with Rheumatoid Arthritis taking conventional DMARD therapy who have moderate disease activity have a similar risk of joint failure that requires surgery as those with high disease activity.

Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network

Authors: Nikiphorou E, Norton SJ, Carpenter L, Walsh DA, Creamer P, Dixey J, Young A, Kiely PDW

Year: 2019

Published by: Rheumatology (Oxford)

Treat to Target in Axial Spondyloarthritis

Authors: Nikiphorou E, Baraliakos X

Year: 2019

Published by: Rheum Dis Clin North Am

Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature

Authors: Fragoulis GE, Conway R, Nikiphorou E.

Year: 2019

Published by: Rheumatology (Oxford)

For more publications by Dr Elena Nikiphorou, see her PubMed linked below.

PubMed: Elena Nikiphorou

Music, dancing.